Lowering cholesterol in old age

Journal of the Royal College of Physicians of London

Volumn 33, Issue 3, 1999, Pages 252-253

  Oliver, M F ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN;

AGED; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MALE; META ANALYSIS; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW; VASCULAR DISEASE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CLINICAL TRIALS; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0033063687     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Ettinger WH, Wahl PW, Kuller LH, Bush TL, et al. Lipoprotein lipids in older people. Circulation 1992;86:858-69.
2. Guyling H, Strandberg T, Tilvis R, Miettinen TA. Regulation of serum cholesterol level in middle-aged and elderly men. Relation of cholesterol absorption and synthesis to lipoprotein metabolism. Arterioscler Thromb 1994;14:694-700.
3. Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, Knook DL, et al. Total cholesterol and risk of mortality in the oldest old. Lancet 1997;350:1119-23.
4. Weijenberg MP, Feskens EJM, Bowles CH, Kromhout D. Serum total cholesterol and systolic blood pressure as risk factors for mortality from ischaemic heart disease among elderly men and women. J Clin Epidemiol 1994;2:197-205.
5. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elderly Study. Am J Epidemiol 1996;143:151-8.
6. Corti M-C, Gurainik JM, Salive ME, Harris T, et al. HDL cholesterol predicts coronary heart disease in older patients. JAMA 1995; 274:539-44.
7. Räihä I, Marniemi J, Puukka P, Tikka T, et al. Effect of serum lipids, lipoproteins, and apolipoprotein on vascular and nonvascular mortality in the elderly. Arterioscler Thromb Vase Biol 1997;17:1224-32.
8. Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction and angina. Circulation 1997;96:4211-18.
9. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001-9.
10. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57
11. Shepherd J, Cobbe SM, Ford I, Isles CG, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995;333:1301-7.
12. Downs JR, Clearfield M, Weis S, Whitney E, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22.
13. Dayton S, Pearce ML, Hashimoto S, et al. A controlled clinical trial of a diet high in unsaturated fat preventing complications in atherosclerosis. Circulation 1969;40(Suppl II):63.
14. Tang JL, Armitage JM, Lancaster T, Silagy CA, et al. Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects. Br Med J 1998;316:1213-19.
15. American College of Physicians. Guidelines for using serum cholesterol, high density lipoprotein cholesterol, and triglycerides as screening tests for preventing coronary heart disease in adults. Ann Intern Med 1996;124:515-17.